🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joanna Bagińska

Harvard University

ORCID: 0000-0001-5182-7575

Also affiliated with Dana-Farber Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates”.

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2250
N/A
0.979DataRank · unranked
35 citations

Michael J. Nathenson, Emanuele Mazzola, Jia‐Ren Lin, Joanna Bagińska, Allison Nau +11 more

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

Cancer Cell(2022)10.1016/j.ccell.2022.10.017
N/A
0.626DataRank · unranked
64 citations

Michelle P. Aranha, Robert Redd, Joanna Bagińska, Nicholas J. Haradhvala, Margaret Hallisey +34 more

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

Cell(2025)10.1016/j.cell.2025.06.019
N/A
0.520DataRank · unranked
31 citations

Derin B. Keskin, Chloe Ran Tu, Cleo Forman, Allison P. Vanasse, Haley E. Sax +39 more

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1027
N/A
0.292DataRank · unranked
6 citations

Osama E. Rahma, Kevin Tyan, Yvonne Li, Anita Giobbie‐Hurder, Benjamin L. Schlechter +18 more

Circulating cytokine associations with clinical outcomes in melanoma patients treated with combination nivolumab plus ipilimumab

OncoImmunology(2024)10.1080/2162402x.2024.2432723
N/A
0.292DataRank · unranked
6 citations

Giuseppe Tarantino, Mariano Severgnini, Joanna Bagińska, Anita Giobbie‐Hurder, Jason L. Weirather +14 more

Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2122379119
N/A
0DataRank · unranked
134 citations

James Dongjoo Ham, Guangan Hu, Guozhu Xie, Juliana Vergara, Yong Liang +12 more